FDA Approves First Booster COVID-19 Vaccine Shots 

 FDA Approves First Booster COVID-19 Vaccine Shots 

The U.S. Food and Drug Administration has amended the emergency use authorization for the Pfizer-BioNTech COVID-19 vaccine to allow for a single booster dose at least six months after completion of the primary series for people 65 years of age and older; those who are 18 through 64 and at high risk of severe COVID-19; and those who are 18 through 64 and whose jobs put them at higher risk of exposure (healthcare, colleges, schools, grocery stores, etc)  

The Pfizer COVID-19 vaccine was recently authorized under the FDA’s normal review and approval process. This emergency use authorization is for the booster shot. Click here for more.   

PA State Association of Township Supervisors

Get In Touch

Mon - Fri, 8:30 am - 4:30 pm

Resources for Township & Municipal Officials

Scroll to Top